Guidelines statements used for benchmarking non-pharmacological therapeutic options.

<p>GOLD 2013: Global Initiative for Obstructive Lung Disease 2013 [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0141856#pone.0141856.ref019" target="_blank">19</a>].</p><p>SEPAR 2009: SEPAR Health-Care Quality Standards 2009 [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0141856#pone.0141856.ref021" target="_blank">21</a>].</p><p>GesEPOC 2012: Spanish National Guidelines for COPD [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0141856#pone.0141856.ref022" target="_blank">22</a>].</p><p>Guidelines statements used for benchmarking non-pharmacological therapeutic options.</p

Recommendations regarding the diagnostic tests.

<p>Recommendations regarding the diagnostic tests.</p

Guidelines statements used for benchmarking the outpatient clinics.

<p>GOLD 2013: Global Initiative for Obstructive Lung Disease 2013 [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0141856#pone.0141856.ref019" target="_blank">19</a>].</p><p>SEPAR 2009: SEPAR Health-Care Quality Standards 2009 [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0141856#pone.0141856.ref021" target="_blank">21</a>].</p><p>GesEPOC 2012: Spanish National Guidelines for COPD [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0141856#pone.0141856.ref022" target="_blank">22</a>].</p><p>Guidelines statements used for benchmarking the outpatient clinics.</p

Recommendations regarding the clinical assessments.

<p>Recommendations regarding the clinical assessments.</p

Clinical characteristics of the audited cases (n = 621).

<p>Clinical characteristics of the audited cases (n = 621).</p

Recommendations regarding the clinical phenotypes and multidimensional evaluation.

<p>Recommendations regarding the clinical phenotypes and multidimensional evaluation.</p

Types of hospitals in Andalusia and their participation in the audit.

<p>Types of hospitals in Andalusia and their participation in the audit.</p

Cases included in the audit according to the enrollment period, sex, and COPD severity stages.

<p>Abbreviations: M:F = males:females; GOLD = Global Initiative for Obstructive Lung Disease.</p><p>Cases included in the audit according to the enrollment period, sex, and COPD severity stages.</p

Recommendations regarding treatment monitoring.

<p>Recommendations regarding treatment monitoring.</p

Characteristics of the participant centers.

<p>Characteristics of the participant centers.</p